Literature DB >> 21725253

Accuracy of frame-based stereotactic magnetic resonance imaging vs frame-based stereotactic head computed tomography fused with recent magnetic resonance imaging for postimplantation deep brain stimulator lead localization.

Patrick Pezeshkian1, Antonio A F DeSalles, Alessandra Gorgulho, Eric Behnke, David McArthur, Ausaf Bari.   

Abstract

BACKGROUND: Introduction of the portable intraoperative CT scanner provides for a precise and cost-effective way of fusing head CT images with high-tesla MRI for the exquisite definition of soft tissue needed for stereotactic targeting.
OBJECTIVE: To evaluate the accuracy of stereotactic electrode placement in patients undergoing deep brain stimulation (DBS) by comparing frame-based postimplantation intraoperative CT (iCT) images fused to a recent 3T-MRI with frame-based postimplantation intraoperative MRI (iMRI) alone.
METHODS: Frame-based DBS surgeries of 46 targets performed from February 8, 2007 to April 28, 2008 in 26 patients with the use of immediate postimplantation iMRI for target localization were compared with frame-based immediate postimplantation iCT fused with a recent 3T brain MRI for DBS localization of 50 targets performed from August 13, 2008 to February 18, 2010 in 26 patients. Pre- and postoperative mid anterior commissure-posterior commissure line coordinates and XYZ coordinates for preoperatively calculated DBS targets (intended target) and for the permanent DBS lead tips were determined. The differences between preoperative DBS target and postoperative permanent DBS lead-tip coordinates based on postimplantation intraoperative MRI for the MRI-alone group and based on postimplantation intraoperative CT fused to recent preoperative MRI in the CT-MRI group were measured. The t test and Yuen test were used for comparison.
RESULTS: No statistically significant differences were found between the 2 groups when comparing the pre- and postperative changes in mid anterior commissure-posterior commissure line coordinates and XYZ coordinates.
CONCLUSION: Postimplantation DBS lead localization and therefore targeting accuracy was not significantly different between frame-based stereotactic 1.5T-MRI and frame-based stereotactic head CT fused with recent 3T-MRI.

Entities:  

Mesh:

Year:  2011        PMID: 21725253     DOI: 10.1227/NEU.0b013e31822b7069

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

1.  Lateralization of the Subthalamic Nucleus with Age in Parkinson's Disease.

Authors:  Julio L B Pereira; Sydney Furie B A; Justin Sharim; Daniel Yazdi; Antonio A F DeSalles; Nader Pouratian
Journal:  Basal Ganglia       Date:  2016-04-01

2.  Influence of the brain function through the peripheral nerves.

Authors:  Antonio De Salles; Alessandra Gorgulho
Journal:  Surg Neurol Int       Date:  2012-10-31

3.  Deep brain stimulation with a pre-existing cochlear implant: Surgical technique and outcome.

Authors:  Daniel Eddelman; Joshua Wewel; R Mark Wiet; Leo V Metman; Sepehr Sani
Journal:  Surg Neurol Int       Date:  2017-04-05

4.  Modeling Laterality of the Globus Pallidus Internus in Patients With Parkinson's Disease.

Authors:  Justin Sharim; Daniel Yazdi; Amy Baohan; Eric Behnke; Nader Pouratian
Journal:  Neuromodulation       Date:  2016-07-28

5.  Geometric accuracy of 3D coordinates of the Leksell stereotactic skull frame in 1.5 Tesla- and 3.0 Tesla-magnetic resonance imaging: a comparison of three different fixation screw materials.

Authors:  Hisato Nakazawa; Yoshimasa Mori; Osamu Yamamuro; Masataka Komori; Yuta Shibamoto; Yukio Uchiyama; Takahiko Tsugawa; Masahiro Hagiwara
Journal:  J Radiat Res       Date:  2014-07-17       Impact factor: 2.724

6.  Accuracy of a magnetic resonance imaging-based 3D printed stereotactic brain biopsy device in dogs.

Authors:  Sarah Gutmann; Dirk Winkler; Marcel Müller; Robert Möbius; Jean-Pierre Fischer; Peter Böttcher; Ingmar Kiefer; Ronny Grunert; Thomas Flegel
Journal:  J Vet Intern Med       Date:  2020-02-24       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.